MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0146520
Subira Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹45.51 Cr
▲ 32% YoY
Net profit · FY 2024
₹4.79 Cr
Net margin 10.5%
EBITDA · FY 2024
₹6.76 Cr
EBITDA margin 14.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Satisfied ₹2.21 Cr
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
About Subira Pharmaceuticals Private Limited
Data last updated:
Subira Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2013PTC328984. Its GSTIN is 27AATCS7963C1ZR (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vishal Khanna and Kavita Khanna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 408 Fairlink Centre Chs Ltd. Off. Link Road Andheri West, Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2024, the company reported a revenue of ₹45.51 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹4.79 Cr (net margin 10.5%) and EBITDA of ₹6.76 Cr (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 25% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹2.21 Cr on record.
Subira Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0146520). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website subirapharma.in.
Company details
CIN U24233MH2013PTC328984
Registration Number 328984
Incorporation Date 08 October 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0146520
CIN history
Subira Pharmaceuticals has one previous CIN (Corporate Identification Number): U24233HR2013PTC050627. The current CIN is U24233MH2013PTC328984, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233MH2013PTC328984 | Current |
| U24233HR2013PTC050627 | Previous |
Key People
Vishal Khanna Director Kavita Khanna Director Recognitions & Rankings of Subira Pharmaceuticals
Contact details
Subira Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is subirapharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA – 408 Fairlink Centre Chs Ltd. Off. Link Road Andheri West, Mumbai, Maharashtra, India – 400053
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Subira Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Subira Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Subira Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Subira Pharmaceuticals Private Limited, buy the company report.
Financials of Subira Pharmaceuticals Private Limited
FY 2025 filings availableSubira Pharmaceuticals Private Limited reported revenue of ₹45.51 Cr (up 32% YoY) for FY 2024.
Revenue · FY 2024
₹45.51 Cr ▲ 32%
Net profit · FY 2024
₹4.79 Cr margin 10.5%
EBITDA · FY 2024
₹6.76 Cr margin 14.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 18%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 84%
3 years · compounded
▲ 2%
5 years · compounded
▲ 34%
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 32% growth in the latest year. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.76 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.79 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.9% | ||||
| Net Profit Margin | 10.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Subira Pharmaceuticals Private Limited, buy the company report.
Board of directors of Subira Pharmaceuticals Private Limited
Subira Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Khanna | Director | 08 Oct 2013 | 13 Years 1 Months | Current |
| Kavita Khanna | Director | 08 Oct 2013 | 13 Years 1 Months | Current |
Auditor
Subira Pharmaceuticals Private Limited is audited by K M GARG & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K M GARG & CO. | FY 2023 | 120712W |
Shareholding
The shareholding of Subira Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Subira Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
₹2.21 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jan 2025 | 101041149 | Hdfc Bank Limited | ₹50 Lakh | Open | |
| 04 May 2022 | 100571724 | Hdfc Bank Limited | ₹25 Lakh | Satisfied | |
| 01 Dec 2020 | 100401055 | Others | ₹1.96 Cr | Satisfied |
To see the full charge records of Subira Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Subira Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Subira Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Subira Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AATCS7963C1ZR | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Subira Pharmaceuticals Private Limited, buy the company report.
Recent activity
Subira Pharmaceuticals Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Kavita Khanna was appointed as Director on 08 Oct 2013.
AGM
Subira Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Subira Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 101041149 was registered on 30 Jan 2025.
Charges
A charge registered on 04 May 2022 via Charge ID 100571724 with Hdfc Bank Limited was fully satisfied on 22 Jan 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 100571724 was registered on 04 May 2022.
Charges
A charge registered on 01 Dec 2020 via Charge ID 100401055 with Others was fully satisfied on 03 Feb 2022.
Charges
A charge with Others amounted to Rs. 195.73 Lakh with Charge ID 100401055 was registered on 01 Dec 2020.
Appointed
Kavita Khanna was appointed as Director.
Appointed
Vishal Khanna was appointed as Director.
Incorporation
08 Oct 2013
Subira Pharmaceuticals Private Limited was registered on 08 Oct 2013 with Roc Mumbai I & aged 13 years 1 month as per MCA records.
Frequently asked questions
Subira Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 October 2013 (13+ years old) and is registered under CIN U24233MH2013PTC328984.
Subira Pharmaceuticals has 2 current directors:
- Vishal Khanna - Director
- Kavita Khanna - Director
The latest financial statements of Subira Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Subira Pharmaceuticals is 27AATCS7963C1ZR, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Subira Pharmaceuticals is U24233MH2013PTC328984. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Subira Pharmaceuticals was incorporated on 08 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Kavita Khanna was appointed as Director on 08 Oct 2013. Vishal Khanna was appointed as Director on 08 Oct 2013.
Yes, Subira Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0146520).
Subira Pharmaceuticals can be reached through the website subirapharma.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Subira Pharmaceuticals is at A – 408 Fairlink Centre Chs Ltd. Off. Link Road Andheri West, Mumbai, Maharashtra, India – 400053.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages